188 related articles for article (PubMed ID: 28814453)
1. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
3. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
[TBL] [Abstract][Full Text] [Related]
4. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
6. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.
Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ
PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920
[TBL] [Abstract][Full Text] [Related]
7. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic Blockade Promotes Maintenance of Dormancy in Prostate Cancer Through Upregulation of GAS6.
Decker AM; Decker JT; Jung Y; Cackowski FC; Daignault-Newton S; Morgan TM; Shea LD; Taichman RS
Transl Oncol; 2020 Jul; 13(7):100781. PubMed ID: 32361123
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.
Jung Y; Shiozawa Y; Wang J; McGregor N; Dai J; Park SI; Berry JE; Havens AM; Joseph J; Kim JK; Patel L; Carmeliet P; Daignault S; Keller ET; McCauley LK; Pienta KJ; Taichman RS
Neoplasia; 2012 May; 14(5):429-39. PubMed ID: 22745589
[TBL] [Abstract][Full Text] [Related]
10. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
[TBL] [Abstract][Full Text] [Related]
11. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
[TBL] [Abstract][Full Text] [Related]
12. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
13. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
14. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
Cackowski FC; Taichman RS
Bone; 2019 Feb; 119():82-86. PubMed ID: 29496517
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of Gas6 in intestinal tumorigenesis.
Akitake-Kawano R; Seno H; Nakatsuji M; Kimura Y; Nakanishi Y; Yoshioka T; Kanda K; Kawada M; Kawada K; Sakai Y; Chiba T
Carcinogenesis; 2013 Jul; 34(7):1567-74. PubMed ID: 23430954
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract][Full Text] [Related]
17. AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.
Axelrod HD; Valkenburg KC; Amend SR; Hicks JL; Parsana P; Torga G; DeMarzo AM; Pienta KJ
Mol Cancer Res; 2019 Feb; 17(2):356-369. PubMed ID: 30291220
[TBL] [Abstract][Full Text] [Related]
18. Biochemical Changes in the Niche Following Tumor Cell Invasion.
Decker AM; Cackowski FC; Jung Y; Taichman RS
J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic nervous system regulates bone marrow-derived cell egress through endothelial nitric oxide synthase activation: role in postischemic tissue remodeling.
Récalde A; Richart A; Guérin C; Cochain C; Zouggari Y; Yin KH; Vilar J; Drouet I; Lévy B; Varoquaux O; Silvestre JS
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):643-53. PubMed ID: 22267478
[TBL] [Abstract][Full Text] [Related]
20. Bone secreted factors induce cellular quiescence in prostate cancer cells.
Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
